Gynecomastia as a complication of auranofin therapy.
Gynecomastia was found in a patient taking 12 mg of auranofin (AF) daily. The gynecomastia was noticed after AF was increased to this dose and resolved after the drug was discontinued. The patient refused rechallenge.
Williams
H J
HJ
Department of Internal medicine, University of Utah Medical Center, Salt Lake City, 84132.
D000328:Adult; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D001310:Auranofin / Q000009:adverse effects* / Q000627:therapeutic use; D006177:Gynecomastia / Q000139:chemically induced*; D006801:Humans; D008297:Male
D001310:Auranofin